Late onset death of motor neurons in mice overexpressing wild-type peripherin

Journal of Cell Biology

Volumn 147, Issue 3, 1999, Pages 531-544

  Beaulieu, Jean Martin ^a   Nguyen, Minh Dang ^a   Julien, Jean Pierre ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

ALS; Motor neuron; Neurofilament; Peripherin; Transgenic

Indexed keywords

CYTOKINE; PERIPHERIN; SUPEROXIDE DISMUTASE; INTERMEDIATE FILAMENT PROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL INCLUSION; GENE OVEREXPRESSION; KNOCKOUT MOUSE; MOTONEURON; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROFILAMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; TRANSGENIC MOUSE; AGING; ANIMAL; CELL DEATH; GENETICS; METABOLISM; MOUSE MUTANT; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

AGING; ANIMALS; CELL DEATH; INTERMEDIATE FILAMENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR NEURONS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; UP-REGULATION;

EID: 0033230327     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.147.3.531     Document Type: Article

References (61)

1. Athlan, E.S., and W.E. Mushynski. 1997. Heterodimeric associations between neuronal intermediate filament proteins. J. Biol. Chem. 272:31073-31078.
2. Bancroft, J.D., and A. Stevens. 1990. Theory and practice of histological techniques. 3rd edition. Churchill Livingstone, Inc. New York, NY. 726 pp.
3. Beaulieu, J.M., J. Robertson, and J.P. Julien. 1999. Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. Biochem. Cell Biol. 77:41-45.
4. Bergeron, C., K. Beric-Maskarel, S. Muntasser, L. Weyer, M.J. Somerville, and M.E. Percy. 1994. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53:221-230.
5. Brinster, R.L., H.Y. Chen, M. Trumbauer, A.W. Senear, R. Warren, and R.D. Palmiter. 1981. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell. 27:223-231.
6. Brody, B.A., C.A. Ley, and L.M. Parysek. 1989. Selective distribution of the 57 kDa neural intermediate filament protein in the rat CNS. J. Neurosci. 9:2391-2401.
7. Bruening, W., B. Giasson, W. Mushynski, and H.D. Durham. 1998. Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter. Nucleic Acids Res. 26:486-489.
8. Bruijn, L.I., M.K. Houseweart, S. Kato, K.L. Anderson, S.D. Anderson, E. Ohama, A.G. Reaume, R.W. Scott, and D.W. Cleveland. 1998. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1851-1854.
9. Bruijn, L.I., M.W. Becher, M.K. Lee, K.L. Anderson, N.A. Jenkins, N.G. Copeland, S.S. Sisodia, J.D. Rothstein, D.R. Borchelt, D.L. Price, and D.W. Cleveland. 1997. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:327-338.
10. Carpenter, S. 1968. Proximal axonal enlargement in motor neuron disease. Neurology. 18:841-851.
11. Ching, G.Y., and R.K.H. Liem. 1993. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122:1323-1335.
12. Ching, G.Y., C.L. Chien, R. Flores, and R.K. Liem. 1999. Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J. Neurosci. 19:2974-2986.
13. Chou, S.M. 1995. Pathology of motor system disorder. In Motor Neuron Disease: Biology and Management. P.N. Leigh and M. Swash, editors. Springer-Verlag, London. 53-92.
14. Corho, M., and A.P. Hays. 1992. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51: 531-537.
15. Côté, F., J.F. Collard, and J.-P. Julien. 1993. Progressive neuropathy in transgenic mce expressing the human neurofilamen heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell. 73:35-46.
16. Crow, J.P., Y.Z. Ye, M. Strong, M. Kirk, S. Barnes, and J.S. Beckman. 1997. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J. Neurochem. 69:1945-1953.
17. Cui, C., P.J. Stambrook, and L.M. Parysek. 1995. Peripherin assembles into homopolymers in SW13 cells. J. Cell Sci. 108:3279-3284.
18. Cummings, C.J., M.A. Mancini, B. Antalffy, D.B. DeFranco, H.T. Orr, H.Y. Zoghbi. 1998. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nature Genet. 19:148-154.
19. Djabali, K., A. Zissopoulou, M.J.D. Hoop, S.D. Georgatos, and C.G. Dotti. 1993. Peripherin expression in hippocampal neurons induced by muscle soluble factors. J. Cell Biol. 123:1197-1206.
20. Escurat, M., K. Djabali, M. Gumpel, F. Gros, and M.M. Portier. 1990. Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecular-mass neurofilament protein NF-L during the development of the rat. J. Neurosci. 10:764-784.
21. Eyer, J., D.W. Cleveland, P.C. Wong, and A.C. Peterson. 1998. Pathogenesis of two axonopathies does not require axonal neurofilaments. Nature. 391:584-587.
22. Feinberg, A.P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
23. Ferri, G.L., A. Sabani, L. Abelli, J.M. Polak, D. Dahl, and M.M. Portier. 1990. Neuronal intermediate filaments in rat dorsal root ganglia: differential distribution of peripherin and neurofilament protein immunoreactivity and effect of capsaicin. Brain Res. 515:331-335.
24. Goldstein, M.E., P. Grant, S.B. House, D.B. Henken, and H. Gainer. 1996. Developmental regulation of two distinct neuronal phenotypes in rat dorsal root ganglia. Neuroscience. 71:243-258.
25. Gurney, M.E., H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.X. Deng, et al. 1994. Motor neuron degeneration in mice that express a human Cu.Zn superoxide dismutase mutation. Science. 264:1772-1775.
26. Ho, C.L., S.S.M. Chin, K. Carnevale, and R.K.H. Liem. 1995. Translation initiation and assembly of peripherin in cultured cells. Eur. J. Cell Biol. 68:103-112.
27. Jacomy, H., and O. Bosler. 1995. Catecholaminergic innervation of the suprachiasmatic nucleus in the adult rat: ultrastructural relationships with neurons containing vasoactive intestinal peptide or vasopressin. Cell Tissue Res. 280: 87-96.
28. Julien, J.P., and W.E. Mushynski. 1998. Neurofilaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol. 61:1-23.
29. Kakizuka, A. 1997. Degenerative ataxias: genetics, pathogenesis and animal models. Curr. Opin. Neurol. 10:285-290.
30. Kato, S., M. Shimoda, Y. Watanabe, K. Nakashima, K. Takahashi, and E. Ohama. 1996. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1: gene multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J. Neuropathol. Exp. Neurol. 55: 1089-1101.
31. Klein, M.A., J.C. Moller, L.L. Jones, H. Bluethmann, G.W. Kreutzberg, and G. Raivich. 1997. Impaired neuroglial activation in interleukin-6 deficient mice. Glia. 19:227-233.
32. Kurek, J.B., T.M. Bennett, J.J. Bower, C.M. Muldoon, and L. Austin. 1998. Leukaemia inhibitory factor (LIF) production in a mouse model of spinal trauma. Neurosci. Lett. 249:1-4.
33. Lecomte, M.J., M. Basseville, F. Landon, V. Karpov, and M. Fauquet. 1998. Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor: involvement of STAT proteins. J. Neurochem. 70:971-982.
34. Lee, M.K., Z. Xu, P.C. Wong, and D.W. Cleveland. 1993. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122:1337-1350.
35. Lee, M.K., J.R. Marszalek, and D.W. Cleveland. 1994. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron. 13:975-988.
36. Lin, C.L., L.A. Bristol, L. Jin, M. Dykes-Hoberg, T. Crawford, L. Clawson, and J.D. Rothstein. 1998. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 20:589-602.
37. Ma, D., L. Descarries, K.D. Micheva, Y. Lepage, J.-P. Julien, and G. Doucet. 1999. Severe neuronal losses with age in the parietal cortex and ventrobasal thalamus of mice transgenic for the human NF-L neurofilament protein. J. Comp. Neurol. 406:433-448.
38. Migheli, A., T. Pezzulo, A. Attanasio, and D. Schiffer. 1993. Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab. Investig. 68:185-191.
39. Muma, N.A., P.N. Hoffman, H.H. Slunt, M.D. Applegate, I. Lieberburg, and D.L. Price. 1990. Alterations in levels of mRNAs coding for neurofilament protein subunits during regeneration. Exp. Neurol. 107:230-235.
40. Nagai, Y., O. Onodera, J. Chun, W.J. Strittmatter, and J.R. Burke. 1999. Expanded polyglutamine domain proteins hind neurofilament and alter the neurofilament network. Exp. Neurol. 155:195-203.
41. Pachter, J.S., and R.K. Liem. 1985. alpha-Internexin, a 66-kD intermediate filament-binding protein from mammalian central nervous tissues. J. Cell Biol. 101:1316-1322.
42. Parhad, I.M., R. Oishi, and A.W. Clark. 1992. GAP-43 gene expression is increased in anterior horn cells of amyotrophic lateral sclerosis. Ann. Neurol. 31:593-597.
43. Parysek, L.M., and R.D. Goldman. 1988. Distribution of a novel 57 kDA intermediate filament IF protein in the nervous system. J. Neurosci. 8:555-563.
44. Parysek, L.M., MA. McReynolds, R.D. Goldman, and C.A. Ley. 1991. Some neural intermediate filaments contain both peripherin and the neurofilament proteins. J. Neurosci. Res. 30:80-91.
45. Ripps, M.E., G.W. Huntley, P.R. Hof, J.H. Morrison, and J.W. Gordon. 1995. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad, Sci. USA. 92:689-693.
46. Rosen, D.R., T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J.P. O'Regan, H.X. Deng, et al. 1993. Mutations in Cu/ Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:59-62.
47. Sambrook, J., E.F. Fritsh, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
48. Sekizawa, T., H. Openshaw, K. Ohbo, K. Sugamura, Y. Itoyama, and J.C. Niland. 1998. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J. Neurol. Sci. 154:194-199.
49. Shibata, N., A. Hirano, M. Kobayashi, T. Siddique, H.X. Deng, W.Y. Hung, T. Kato, and K. Asayama. 1996. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. Neuropathol. Exp. Neurol. 55: 481-490.
50. Sterneck, E., D.R. Kaplan, and P.F. Johnson. 1996. Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J. Neurochem. 67:1365-1374.
51. Troy, C.M., N.A. Muma, L.A. Greene, D.L. Price, and M.L. Shelanski. 1990a. Regulation of peripherin and neurofilament expression in regenerating rat motor neurons. Brain Res. 529:232-238.
52. Troy, C.M., K. Brown, L.A. Greene, and M.L. Shelanski. 1990b. Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo. Neuroscience. 30:217-237.
53. Tu, P.H., P. Raju, K.A. Robinson, M.E. Gurney, J.O. Trojanowski, and V.M. Lee. 1996. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA. 93:3155-3160.
54. Tu, P.H., K.A. Robinson, F. de Snoo, J. Eyer, A. Peterson, V.M. Lee, and J.Q. Trojanowski. 1997. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice. J. Neurosci. 17:1064-1074.
55. van Rijs, J., V. Giguere, J. Hurst, T. van Agthoven, A. Geurts van Kessel, S. Goyert, and F. Grosveld. 1985. Chromosomal localization of the human Thy-1 gene. Proc. Natl. Acad. Sci. USA. 82:5832-5835.
56. Williamson, T.L., L.I. Bruijn, O. Zhu, K.L. Anderson, S.D. Anderson, J.P. Julien, and D.W. Cleveland. 1998. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA. 95:9631-9636.
57. Williamson, T.L., and D.W. Cleveland. 1999. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:50-56.
58. Wong, P.C., C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, N.A. Jenkins, S.S. Sisodia, D.W. Cleveland, and D.L. Price. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14:1105-1116.
59. Xu, Z., L.C. Cork, J.W. Griffin, and D.W. Cleveland. 1993. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 73:23-33.
60. Zhang, B., P.H. Tu, F. Abtahian, J.Q. Trojanowski, and V.M.Y. Lee. 1997. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139:1307-1315.
61. Zhu, Q., S. Couillard-Després, and J.P. Julien. 1997. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148:299-316.